Evidence map›Paper›PMID 41676152›Full record

ArticleFrontiers in immunology2026

Isoimperatorin alleviates fungal keratitis by regulating NF-κB pathway and macrophage immune response.

Shiqi Song, Huirong Xu, Mengzhu Liu, Qiang Xu, Ling Wang, Fenglei Wang, Xiaomei Wan, Xiaoyan Sun, Chengye Che

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shiqi Song *Department of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Huirong Xu *Institute of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China.
Mengzhu Liu *Department of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Qiang XuDepartment of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Ling WangDepartment of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Fenglei WangDepartment of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Xiaomei WanDepartment of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Xiaoyan SunDepartment of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Chengye CheDepartment of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The purpose of this research study was to investigate the impact of isoimperatorin on Aspergillus fumigatus (A. fumigatus) keratitis and elucidate its underlying mechanisms via the TLR4/MyD88/IKK/NF-κB signaling pathway. Materials and methods: The targets of the active ingredient isoimperatorin were identified via network pharmacology. Key interactions between isoimperatorin and its predicted targets were validated using molecular docking. Results: Isoimperatorin inhibited TLR4/MyD88 complex formation and IKK/NF-κB phosphorylation, downregulated pro-inflammatory cytokines, reduced neutrophil infiltration, and promoted macrophage polarization from the M1 to the M2 phenotype. Additionally, it inhibited cell apoptosis and alleviated corneal epithelial damage. Conclusion: This study demonstrates that isoimperatorin exerts a protective effect against A. fumigatus keratitis primarily by modulating the host immune response. The mechanism is mediated through the multi-target inhibition of the TLR4/MyD88/IKK/NF-κB pathway, leading to a coordinated reduction in inflammation and tissue damage. These findings highlight the therapeutic potential of isoimperatorin as a novel immunomodulatory strategy for managing fungal keratitis.

Indexed as

AspergillosisAspergillus fumigatusEye Infections, FungalKeratitisMacrophagesNF-kappa BAnimalsApoptosisDisease Models, AnimalMiceMice, Inbred C57BLMyeloid Differentiation Factor 88RAW 264.7 CellsSignal TransductionToll-Like Receptor 4Myd88 protein, mouseMyeloid Differentiation Factor 88NF-kappa BToll-Like Receptor 4fungal keratitisimmune responseisoimperatorinnetwork pharmacologyTLR4/MyD88/IKK/NF-κB pathway

Identifiers

PMID41676152
PMCPMC12885997

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.